– USA, NC – Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and industrial solutions, today announced the appointments of Mark Stevenson and Michael Stubblefield to its Board of Directors, effective on July 28, 2022.
Board Chairman and CEO, Vicente Reynal commneted. “I’m excited to welcome Mark and Michael to our Board. We have always focused on new board members who bring experience and perspectives aligned with our key strategies. Mark and Michael are no exception. Mark’s experience in leading a growth compounder in sustainable end markets such as life sciences and medical aligns closely with our long-term vision for Ingersoll Rand, and his experience with machine learning systems supports our innovation in the areas of digitalization and IIoT. At Avantor, Michael has led a dramatic portfolio evolution since being named CEO, and has positioned the company as a leader in life sciences through new product innovation, organic growth and strategic M&A, which are three critical focus areas for us as well. Their knowledge and insights will be powerful additions as we continue on our path of becoming a growth compounder through expansion in sustainable end markets, product innovation and M&A. I look forward to their contributions.”
About Mark Stevenson
Mr. Stevenson is the former EVP and COO of Thermo Fisher Scientific Inc., a Fortune 100 company and world leader in serving science through its life science solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services. He held this role from 2017 until his retirement in 2022. He joined the company in 2014 as EVP and President of Life Sciences Solutions through the acquisition of Life Technologies. Mr. Stevenson previously served as President and COO of Life Technologies, and President and COO of Applied Biosystems before its merger with Invitrogen Corporation in 2008.
He has an MBA from Henley Management College, United Kingdom, and a bachelor’s degree in chemistry from the University of Reading, United Kingdom.
About Michael Stubblefield
Michael Stubblefield currently serves as the President and CEO and Board member of Avantor, a Fortune 500 company and leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education, government, and advanced technologies, and applied materials industries. Before becoming CEO of Avantor in 2014, Mr. Stubblefield served as a senior expert in the Chemicals Practice for McKinsey & Company. Before joining McKinsey, he held various leadership roles at Celanese Corporation, including VP and GM, Advanced Engineered Materials, and CMO.
Mr. Stubblefield earned an MBA from Texas A&M University-Corpus Christi and a bachelor’s degree in chemical engineering from the University of Utah.
About Ingersoll Rand Inc.
Ingersoll Rand Inc., driven by an entrepreneurial spirit and ownership mindset, is dedicated to helping make life better for our employees, customers, and communities. Customers lean on us for our technology-driven excellence in mission-critical flow creation and industrial solutions across 40+ respected brands where our products and services excel in the most complex and harsh conditions. Our employees develop customers for life through their daily commitment to expertise, productivity, and efficiency.
For more information: https://www.irco.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
